Visit the News Center Even short interventions are associated with changes in the risk of heart attack, stroke, and death Sarah Moser and Alaska Adams/Washio Medicine WashU drug researchers have found that stopping GLP-1 drugs like semaglutide and terzepatide — even temporarily — increases the risk of heart attack, stroke and death compared to staying … Read more
Your support helps us tell the story From birth rights to climate change to Big Tech, The Independent is on the ground when the story develops. Whether it’s investigating Elon Musk’s pro-Trump PAC finances or producing our recent documentary ‘The Word,’ which shines a light on American women fighting for reproductive rights, we know how … Read more
go away Spend a few minutes scrolling through social media, and you might come across a train of health influencers who swear that chia seeds have helped them lose weight. But how true are these claims? Chances are, making these little seeds a regular part of your diet might actually make it easier to reach … Read more
1 Ozympic is not FDA approved for weight loss. Providers may, at their clinical discretion, remove it from the label if deemed appropriate for their patient. of the 2 With a low-calorie diet and increased physical activity. In a 71-week double-blind, placebo-controlled trial, 27.9% of overweight or obese participants receiving oral semaglutide 25 mg lost … Read more
The word “eye twitching” has been popping up in the news lately about a very rare side effect of weight loss injections. It is not an official medical diagnosis, but an acronym used to describe a condition in which reduced blood flow damages the optic nerve and causes sudden vision loss. The phrase may be … Read more
Weight-loss medications have been associated with an increased risk of preterm birth among women who took them before pregnancy or during early pregnancy to treat preexisting diabetes. However, a large study of more than 750,000 pregnancies found that weight loss medication use was not associated with preterm birth or other birth complications. study authors, in … Read more
Generally, when investors are looking for growth, they turn to industries like technology. Here, revenues may rise in double or even triple digits, leading to explosive stock performance. But in recent years, a unique area of the pharmaceutical market has presented such an opportunity. And it’s in the weight loss drug space. just now, Eli … Read more
Generally, when investors are looking for growth, they turn to industries like technology. Here, revenues may rise in double or even triple digits, leading to explosive stock performance. But in recent years, a unique area of the pharmaceutical market has presented such an opportunity. And it’s in the weight loss drug space. just now, Eli … Read more
Drugs such as semaglutide (Ozempac, Vigovi) and terzapatide (Monjaro, Zipbound) have changed the landscape of weight management, offering hope where traditional methods have stalled. Both drugs work by mimicking gut hormones that regulate insulin release, slow digestion and reduce appetite, with the overall effect of making you feel fuller faster and for longer. Many patients … Read more
If there is a habit experts constantly recommend to support GLP-1, it gives priority to protein. Foods that include enough protein cause a strong release of the hormone, helping you feel fuller for longer. “Protein is one of the most powerful direct stimulators of GLP-1 release,” says Dr. Jean-Marc Sobchak, a doctor of naturopathy in … Read more